Ovagen Overview

  • Founded
  • 2000
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Ovagen General Information


Developer of a process of producing germ-free (GF) chicken eggs and birds in commercial quantities designed to be used primarily in pharmaceutical industries. The company's process facilitates large-scale production of recombinant proteins to GMP standard using a transgenic chicken platform, enabling pharmaceutical industry to have safe, biosecure, large scale, flexible and cost-effective biomanufacturing platform for the production of vaccines and therapeutic proteins.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Animal Husbandry
Other Industries
Primary Office
  • Carrentrila
  • Country Mayo
  • Ballina
  • Ireland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ovagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Sep-2018 000.00 Completed Out of Business
4. Later Stage VC 01-Jan-2010 00000 000.00 Completed Generating Revenue
3. Later Stage VC 01-Jan-2009 000.00 Completed Generating Revenue
2. Later Stage VC 01-Apr-2008 $12.4M $12.4M Completed Generating Revenue
1. Angel (individual) 01-Jan-2007 Completed Generating Revenue
To view Ovagen’s complete valuation and funding history, request access »

Ovagen Executive Team (2)

Name Title Board Seat Contact Info
Leonard Moran Owner, Founder & Chief Executive Officer
Catherine Caulfield Ph.D Chief Operating Officer
To view Ovagen’s complete executive team members history, request access »